BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity
The market for obesity drugs is projected to exceed $77 billion by 2030
Dr. Randy Seeley, a recognized expert on novel treatments for obesity, to lead study
Related news for (BFRG)
- BullFrog AI Announces Strategic Collaboration with Sygnature Discovery to Introduce BullFrog Data Networks™ to Global Biopharma Clients
- Join Bullfrog AI’s Exclusive Live Investor Webinar and Q&A Session on April 23
- Don’t Miss Out: MoBot’s Latest Stock Updates 04/11/25 03:00 PM
- Today’s Top Performers: MoBot’s Market Review 04/11/25 02:00 PM
- MoBot’s Stock Market Highlights – 04/11/25 01:00 PM